GSA Capital Partners »

Tg Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $394k 11k 36.16
2025-03-31 $224k 5.7k 39.44
2024-09-30 $257k 11k 23.39
2024-06-30 $435k 25k 17.79
2023-09-30 $191k 23k 8.36
2023-06-30 $1.8M 72k 24.85
2023-03-31 $503k 33k 15.05
2022-12-31 $1.6M 132k 11.83
2022-09-30 $234k 40k 5.93
2022-06-30 $192k 45k 4.24
2022-03-31 $601k 63k 9.51
2021-12-31 $204k 11k 18.99
2020-12-31 $335k 6.4k 52.00
2019-09-30 $343k 61k 5.61